跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ORFADIN nitisinone 4 mg/mL oral suspension bottle
Approved
STANDARD
ORFADIN nitisinone 4 mg/mL oral suspension bottle
A Menarini Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c160fc94fbf63a48
Company
A Menarini Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c160fc94fbf63a48
Product Name
ORFADIN nitisinone 4 mg/mL oral suspension bottle
Artg Id
297736
Artg Name
ORFADIN nitisinone 4 mg/mL oral suspension bottle
Sponsor
A Menarini Australia Pty Ltd
Artg Date
2019-02-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a020c9efcce729f01dc9123fa948b3e7.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/87500e92de8dd3bdd3d086f7c03f31f4.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c160fc94fbf63a48
Type
Standard
Back to TGA Approvals
ORFADIN nitisinone 4 mg/mL oral suspension bottle - TGA Drug Approval Details
